Evercore ISI Group Downgrades Hologic to In-Line, Announces $80 Price Target
Evercore ISI Group analyst Vijay Kumar downgrades Hologic (NASDAQ:HOLX) from Outperform to In-Line and announces $80 price target.
Here Are All The Companies With Super Bowl LVI Commercials
Super Bowl LVI aired Sunday on NBC, a unit of Comcast Corp (NASDAQ: CMCSA). The Los Angeles Rams were the winners of the game and ended the NFL season as champions.
Analyst Ratings For Hologic
Over the past 3 months, 5 analysts have published their opinion on Hologic (NASDAQ:HOLX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Morgan Stanley Maintains Equal-Weight on Hologic, Lowers Price Target to $75
Morgan Stanley analyst David Lewis maintains Hologic (NASDAQ:HOLX) with a Equal-Weight and lowers the price target from $76 to $75.
Hologic Sees FY22 Revenue $4.4B-$4.5B
Current Guidance
Previous Guidance
Guidance $
Reported %
Increase
(Decrease)
Constant Currency
%
The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
Here's a roundup of top developments in the biotech space over the last 24 hours.
Earnings Scheduled For February 2, 2022
Companies Reporting Before The Bell
• Sony Group (NYSE:SONY) is likely to report quarterly earnings at $1.57 per share on revenue of $24.59 billion.
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.
Watching COVID Testing Plays Following Report US Insurers Have Said They Will Cover Up To 8 Home COVID Tests/Month
-Bloombering citing Associated Press